For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Blend Labs Inc’s stock clocked out at $3.19, down -2.74% from its previous closing price of $3.28. In other words, the price has decreased by -$2.74 from its previous closing price. On the day, 2.59 million shares were traded. BLND stock price reached its highest trading level at $3.335 during the session, while it also had its lowest trading level at $3.11.
Ratios:
To gain a deeper understanding of BLND’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 3.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JMP Securities on December 18, 2024, initiated with a Mkt Outperform rating and assigned the stock a target price of $7.
On August 12, 2024, Canaccord Genuity Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $3 to $4.75.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 10 ’25 when Haveli Investments, L.P. bought 1,062,317 shares for $3.09 per share. The transaction valued at 3,281,285 led to the insider holds 3,123,242 shares of the business.
Haveli Investments, L.P. bought 1,416,037 shares of BLND for $4,320,754 on Mar 07 ’25. The Director now owns 2,060,925 shares after completing the transaction at $3.05 per share. On Mar 06 ’25, another insider, Haveli Investments, L.P., who serves as the Director of the company, bought 587,149 shares for $3.05 each. As a result, the insider paid 1,790,863 and bolstered with 644,888 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLND now has a Market Capitalization of 828321792 and an Enterprise Value of 1000420928. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.11. Its current Enterprise Value per Revenue stands at 6.175 whereas that against EBITDA is -24.787.
Stock Price History:
The Beta on a monthly basis for BLND is 1.19, which has changed by 0.12720847 over the last 52 weeks, in comparison to a change of -0.034466684 over the same period for the S&P500. Over the past 52 weeks, BLND has reached a high of $5.53, while it has fallen to a 52-week low of $2.08. The 50-Day Moving Average of the stock is -11.35%, while the 200-Day Moving Average is calculated to be -13.75%.
Shares Statistics:
It appears that BLND traded 3.49M shares on average per day over the past three months and 4021290 shares per day over the past ten days. A total of 254.43M shares are outstanding, with a floating share count of 204.96M. Insiders hold about 21.07% of the company’s shares, while institutions hold 50.98% stake in the company. Shares short for BLND as of 1741910400 were 9273106 with a Short Ratio of 2.66, compared to 1739491200 on 8600104. Therefore, it implies a Short% of Shares Outstanding of 9273106 and a Short% of Float of 3.83.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
